Liposomal cisplatin in combination with gemcitabine for untreated locally advanced or metastatic pancreatic cancer
 
Status In progress
Process STA
Referral date 01 November 2014
Description

Scoped as part of Batch 37

 

Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC

Project Team

Associate Director: TBC
Communications manager: TBC
Project manager:

TBC

Technical Advisor: TBC
Technical Lead: TBC

Timeline

Key events during the development of the guidance:

Date Update
22 January 2015 Following on from advice received from the company, the dates for this appraisal will be confirmed once regulatory approval timelines are established.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance